Apple CEO Tim Cook delivers remarks before the start of an Apple event at the Apple headquarters in Cupertino, California, on Sept. 9, 2024.
Justin Sullivan | Getty Images
I tested the new hearing health features coming to Apple‘s AirPods Pro 2 headphones, and they saved me a long-overdue trip to the audiologist.
Apple unveiled the features during an event in September, and they will be publicly available through a free software update next week. Users can take a clinically validated hearing test with the AirPods Pro 2, and the buds will serve as an over-the-counter hearing aid if applicable. The headphones will also be equipped with new hearing protection capabilities, such as loud sound reduction, that are switched on by default.
More than 1.5 billion people are living with hearing loss, according to the World Health Organization. Tapping into this market could help Apple juice sales for the $249 AirPods Pro 2, which the company first launched two years ago.
If you already own the headphones, the hearing health features are worth exploring. They take just a few minutes to set up, and they’re easy to use from the comfort of your home. The AirPods Pro 2 are also a cost-effective option for those looking for assistive hearing technology. Other over-the-counter hearing aids can cost thousands of dollars without insurance, for instance.
Taking the hearing test
Kif Leswing/CNBC
I have a pair of third-generation AirPods that I use every day, but this was my first time trying the AirPods Pro 2. I took them straight out of the box, flipped open the lid to the charging case and paired them with an iPhone. After that, I popped them in my ears and prepared to take Apple’s hearing test.
During its event in September, Apple said 80% of adults in the U.S. have not had their hearing checked in the past five years. That’s certainly true in my case. The last time I remember getting my hearing tested was in elementary school.
Admittedly, I haven’t gone out of my way to protect my hearing, so I wasn’t sure what my results would look like. I felt a little nervous beforehand.
To access the test, you can go into the Health app or into the earbuds’ settings menu. I pulled it up, and it prompted me with a few basic questions about my age, my health and whether I’d been exposed to a loud environment in the past 24 hours.
You need to be in a very quiet space to take the test. Apple runs a background noise test to ensure your environment is suitable, and then it assesses the fit of your headphones within your ears. The AirPods Pro 2 come with medium-sized flexible ear tips attached, but there are extra small, small and large tip sizes included in the box. Apple sells a set of ear tips on its website for about $13 if you’ve misplaced yours.
I took the test in my apartment, and I didn’t need to adjust the fit of the headphones. I read the test’s instructions and then it was time to get started.
The hearing test plays a series of tones at different volumes and frequencies, and you tap the screen each time you hear a sound. It started with my left ear and moved to my right, and it took a little more than five minutes.
The hearing test was easy. There are some long pauses between tones, so I felt like I second-guessed myself occasionally. And Apple isn’t kidding about finding a quiet space to take this test. Some of the tones were so soft that I practically had to hold my breath to hear them. My test also automatically paused a few times as traffic passed by outside, so I’d recommend finding a room that’s as close to silent as possible.
You can take the test as many times as you want, and you’ll get your results as soon as you’re done. A copy is stored in the Health app, and you can share it with your doctor.
I learned that I have little to no hearing loss in both ears, though there are some frequencies that might be harder for me to pick up on. It’s nice to have that peace of mind.
Using your headphones as a hearing aid
Since I have minimal hearing loss, I was prompted to turn on a feature called “Media Assist,” which uses my hearing test results to adjust the clarity of my calls, music and videos based on my specific profile.
I had Media Assist enabled as I used the AirPods Pro 2 to FaceTime friends and family, watch CNBC and listen to different genres of music on Spotify. I didn’t hear much of a difference with music or TV, but I did notice that voices seemed amplified on my FaceTime calls. It’s a subtle change, but I found it helpful.
If your test results show you have mild to moderate hearing loss, you’ll be prompted to set up and use your headphones as a clinical-grade hearing aid. The U.S. Food and Drug Administration approved Apple’s hearing aid software in September.
“After you take a hearing test, your AirPods Pro are transformed into a personalized hearing aid, boosting the specific sounds you need in real time, like parts of speech, or elements within your environment,” Dr. Sumbul Desai, Apple’s vice president of health, said in a prerecorded video last month.
The hearing aid feature is intended for adults with mild to moderate hearing loss, but users can turn it on in their settings even if they don’t fall under that category. Out of curiosity, I switched it on while walking around New York City, running errands, watching TV and chatting with my roommates.
The feature instantly amplified the world around me, and I joked that it felt like a superpower. It was easier for me to hear quiet dialogue on TV, and my conversations were magnified. Interestingly, I didn’t feel overwhelmed by the loud sounds of the city, which I suspect is due to the earbuds’ new hearing protection features.
Using a hearing aid can take some getting used to, so don’t worry if it doesn’t feel natural right away. You can also make specific adjustments to your liking in your settings and the iOS Control Center.
The hearing aid feature was cool to try, even if I don’t need to use it. It would be nice to switch it on in a crowded New York City restaurant, but otherwise, I got the support I needed from the Media Assist feature.
If you have mild to moderate hearing loss and are prompted to turn on the hearing aid feature, Media Assist will also be activated. Your AirPods Pro 2 will automatically adjust as you make calls, watch videos and listen to music across all your Apple devices.
Though I wasn’t the ideal candidate for the hearing aid, I’m excited to tell my parents and grandparents about it. Since the AirPods Pro 2 look like any other pair of Apple headphones, they’re less conspicuous than many existing hearing aids, which I expect will be an added perk for many users.
Startup Figure AI is developing general-purpose humanoid robots.
Figure AI
Figure AI, an Nvidia-backed developer of humanoid robots, was sued by the startup’s former head of product safety who alleged that he was wrongfully terminated after warning top executives that the company’s robots “were powerful enough to fracture a human skull.”
Robert Gruendel, a principal robotic safety engineer, is the plaintiff in the suit filed Friday in a federal court in the Northern District of California. Gruendel’s attorneys describe their client as a whistleblower who was fired in September, days after lodging his “most direct and documented safety complaints.”
The suit lands two months after Figure was valued at $39 billion in a funding round led by Parkway Venture Capital. That’s a 15-fold increase in valuation from early 2024, when the company raised a round from investors including Jeff Bezos, Nvidia, and Microsoft.
In the complaint, Gruendel’s lawyers say the plaintiff warned Figure CEO Brett Adcock and Kyle Edelberg, chief engineer, about the robot’s lethal capabilities, and said one “had already carved a ¼-inch gash into a steel refrigerator door during a malfunction.”
The complaint also says Gruendel warned company leaders not to “downgrade” a “safety road map” that he had been asked to present to two prospective investors who ended up funding the company.
Gruendel worried that a “product safety plan which contributed to their decision to invest” had been “gutted” the same month Figure closed the investment round, a move that “could be interpreted as fraudulent,” the suit says.
The plaintiff’s concerns were “treated as obstacles, not obligations,” and the company cited a “vague ‘change in business direction’ as the pretext” for his termination, according to the suit.
Gruendel is seeking economic, compensatory and punitive damages and demanding a jury trial.
Figure didn’t immediately respond to a request for comment. Nor did attorneys for Gruendel.
The humanoid robot market remains nascent today, with companies like Tesla and Boston Dynamics pursuing futuristic offerings, alongside Figure, while China’s Unitree Robotics is preparing for an IPO. Morgan Stanley said in a report in May that adoption is “likely to accelerate in the 2030s” and could top $5 trillion by 2050.
Concerns about stock valuations in companies tied to artificial intelligence knocked the market around this week. Whether these worries will recede, as they did Friday, or flare up again will certainly be something to watch in the days and weeks ahead. We understand the concerns about valuations in the speculative aspects of the AI trade, such as nuclear stocks and neoclouds. Jim Cramer has repeatedly warned about them. But, in the past week, the broader AI cohort — including real companies that make money and are driving what many are calling the fourth industrial revolution — has been getting hit. We own many of them: Nvidia and Broadcom on the chip side, and GE Vernova and Eaton on the derivative trade of powering these energy-gobbling AI data centers. That’s not what should be happening based on their fundamentals. Outside of valuations, worries also center on capital expenditures and the depreciation that results from massive investments in AI infrastructure. On this point, investors face a choice. You can go with the bears who are glued to their spreadsheets and extrapolating the usable life of tech assets based on history, a seemingly understandable approach, and applying those depreciation rates to their financial models, arguing the chips should be near worthless after three years. Or, you can go with the commentary from management teams running the largest companies driving the AI trade, and what Jim has gleaned from talking with the smartest CEOs in the world. When it comes to the real players driving this AI investment cycle, like the ones we’re invested in, we don’t think valuations are all that high or unreasonable when you consider their growth rates and importance to the U.S., and by extension, the global economy. We’re talking about Nvidia CEO Jensen Huang, who would tell you that advancements in his company’s CUDA software have extended the life of GPU chip platforms to roughly five to six years. Don’t forget, CoreWeave recently re-contracted for H100s from Nvidia, which were released in late 2022. The bears with their spreadsheets would tell you those chips are worthless. However, we know that H100s have held most of their value. Or listen to Lisa Su, CEO of Advanced Micro Devices , who said last week that her customers are at the point now where “they can see the return on the other side” of these massive investments. For our part, we understand the spending concerns and the depreciation issues that will arise if these companies are indeed overstating the useful lives of these assets. However, those who have bet against the likes of Jensen Huang and Lisa Su, or Meta Platforms CEO Mark Zuckerberg, Microsoft CEO Satya Nadella, and others who have driven innovation in the tech world for over a decade, have been burned time and again. While the bears’ concerns aren’t invalid, long-term investors are better off taking their cues from technology experts. AI is real, and it will increasingly lead to productivity gains as adoption ramps up and the technology becomes ingrained in our everyday lives, just as the internet has. We have faith in the management teams of the AI stocks in which we are invested, and while faith is not an investment strategy, that faith is based on a historical track record of strong execution, the knowledge that offerings from these companies are best in class, and scrutiny of their underlying business fundamentals and financial profiles. Siding with these technology expert management teams, over the loud financial expert bears, has kept us on the right side of the trade for years, and we don’t see that changing in the future. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust, including NVDA, AVGO, GEV, ETN, META, MSFT.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: The S & P 500 bounced back Friday, recovering from the prior session’s sharp losses. The broad-based index, which was still tracking for a nearly 1.5% weekly decline, started off the session a little shaky as Club stock Nvidia drifted lower after the open. It was looking like concerns about the artificial intelligence trade, which have been dogging the market, were going to dominate back-to-back sessions. But when New York Federal Reserve President John Williams suggested that central bankers could cut interest rates for a third time this year, the market jumped higher. Rate-sensitive stocks saw big gains Friday. Home Depot rose more than 3.5% on the day, mitigating a tough week following Tuesday’s lackluster quarterly release. Eli Lilly hit an all-time high, becoming the first drugmaker to reach a $1 trillion market cap. TJX also topped its all-time high after the off-price retailer behind T.J. Maxx, Marshalls, and HomeGoods, delivered strong quarterly results Wednesday. Carry trade: We’re also monitoring developments in Japan, which is dealing with its own inflation problem and questions about whether to resume interest rate hikes. That brings us to the popular Japanese yen carry trade, which is getting squeezed as borrowing costs there are rising. The yen carry trade involves borrowing yen at a low rate, then converting them into, say, dollars, and investing in higher-yielding foreign assets. That’s all well and good when the cost to borrow yen is low. It’s a different story now that borrowing costs in Japan are hitting 30-year highs. When rates rise, the profit margin on the carry trade gets crunched, or vanishes completely. As a result, investors need to get out, which means forced selling and price action that becomes divorced from fundamentals. It’s unclear if any of this is adding pressure to U.S. markets. We didn’t see anything in the recent quarterly earnings reports from U.S. companies to suggest corporate fundamentals are deteriorating in any meaningful way. That’s why we’re looking for other potential external factors, alongside the well-known concerns about artificial intelligence spending, the depreciation resulting from those capital expenditures, and general worries about consumer sentiment and inflation here in America. Wall Street call: HSBC downgraded Palo Alto Networks to a sell-equivalent rating from a hold following the company’s quarterly earnings report Wednesday. Analysts, who left their $157 price target unchanged, cited decelerating sales growth as the driver of the rerating, describing the quarter as “sufficient, not transformational.” Still, the Club name delivered a beat-and-raise quarter, which topped estimates across every key metric. None of this stopped Palo Alto shares from falling on the release. We chalked the post-earnings decline up to high expectations heading into the quarter, coupled with investor concerns over a new acquisition of cloud management and monitoring company Chronosphere. Palo Alto is still working to close its multi-billion-dollar acquisition of identity security company CyberArk , announced in July. HSBC now argues the stock’s risk-versus-reward is turning negative, with limited potential for upward estimate revisions for fiscal years 2026 and 2027. We disagree with HSBC’s call, given the momentum we’re seeing across Palo Alto’s businesses. The cybersecurity leader is dominating through its “platformization” strategy, which bundles its products and services. Plus, Palo Alto keeps adding net new platformizations each quarter, converting customers to use its security platform, and is on track to reach its fiscal 2030 target. We also like management’s playbook for acquiring businesses just before they see an industry inflection point. With Chronosphere, Palo Alto believes the entire observability industry needs to change due to the growing presence of AI. We’re reiterating our buy-equivalent 1 rating and $225 price target on the stock. Up next: There are no Club earnings reports next week. Outside of the portfolio, Symbotic, Zoom Communications , Semtech , and Fluence Energy will report after Monday’s close. Wall Street will also get a slew of delayed economic data during the shortened holiday trading week. U.S. retail sales and September’s consumer price index are scheduled for release early Tuesday. Durable goods orders and the Conference Board consumer sentiment are released on Wednesday morning. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.